​Published bi-monthly, Journal of Addiction Medicine (JAM) is the official journal of the American Society of Addiction Medicine. JAM promotes excellence in the practice of addiction medicine and clinical research and supports addiction medicine as a mainstream medical specialty.  

ASAM invites applications for the positions of Co-Editor and Editorial Fellow. The Co-Editor will contribute to the vision, energy, and leadership of the Editor-in-Chief and other Co-Editors to support JAM as a leading professional clinical journal. The Co-Editor’s responsibilities include evaluating manuscripts for publication including obtaining and incorporating peer reviews, and, in concert with the Editor-in-Chief and Co-Editors, contributing to the direction of the Journal. Co-editors are expected to have substantial experience with publishing peer-reviewed papers.

Under JAM editors’ supervision, the Editorial Fellow will engage in mentored manuscript review, participate in regular editor meetings, and depending on the level of experience and interest the Fellow may write or co-write editorials for the journal. Editorial fellows are anticipated to be junior faculty who are pursuing academic careers that will have publishing as a substantial component.

Interested individuals are referred to the position descriptions online at https://www.asam.org/about-us/jobs for detailed information about qualifications, duties, and responsibilities. Applications for the position of Editorial Fellow must be received by close of Business on October 15, 2018, and for the Co-editor by close of business on October 28, 2018.

Read the article about the new National Practice Guideline from the American Society of Addiction Medicine on the Use of Medication in the Treatment of Addiction Involving Opioid Use from the American Society of Addiction Medicine. Read the article about the Guideline here.

Today, marks an historic day as ASAM convened stakeholders, including several medical societies, eight federal agencies, patient and payers organizations at the National Press Club in Washington, DC, for a press conference and stakeholder summit to announce and accelerate the adoption of its newly released National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use (National Practice Guideline) and associated products. The meeting … Read more about the conference here.